Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Levonorgestrel API Market Growth 2022-2028

  • LP 4832699
  • 114 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Levonorgestrel API will have significant change from previous year. According to our (LP Information) latest study, the global Levonorgestrel API market size is USD million in 2022 from USD 47 million in 2021, with a change of % between 2021 and 2022. The global Levonorgestrel API market size will reach USD 62 million in 2028, growing at a CAGR of 4.1% over the analysis period.

The United States Levonorgestrel API market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Levonorgestrel API market, reaching US$ million by the year 2028. As for the Europe Levonorgestrel API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Levonorgestrel API players cover ScinoPharm, Altaris (3M Drug Delivery Systems), Bayer, and Cipla, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Levonorgestrel API market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Short-Acting Contraceptive API

Long-Acting Contraceptive API

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Table

Mixture Products

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

ScinoPharm

Altaris (3M Drug Delivery Systems)

Bayer

Cipla

Formos

FORTEQ NIDAU AG

Gedeon Richter

Hangzhou Longshine Bio-Tec

Hubei Gedian Humanwell Pharmaceutical

Indo Phyto Chemicals

Industriale Chimica

Jenapharm

Lupin

Naari

Qinhuangdao Zizhu Pharmaceutical

Sterling Chemical Malta Ltd

Symbiotec Pharmalab

Yangzhou Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Levonorgestrel API Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Levonorgestrel API by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Levonorgestrel API by Country/Region, 2017, 2022 & 2028

2.2 Levonorgestrel API Segment by Type

2.2.1 Short-Acting Contraceptive API

2.2.2 Long-Acting Contraceptive API

2.3 Levonorgestrel API Sales by Type

2.3.1 Global Levonorgestrel API Sales Market Share by Type (2017-2022)

2.3.2 Global Levonorgestrel API Revenue and Market Share by Type (2017-2022)

2.3.3 Global Levonorgestrel API Sale Price by Type (2017-2022)

2.4 Levonorgestrel API Segment by Application

2.4.1 Table

2.4.2 Mixture Products

2.4.3 Other

2.5 Levonorgestrel API Sales by Application

2.5.1 Global Levonorgestrel API Sale Market Share by Application (2017-2022)

2.5.2 Global Levonorgestrel API Revenue and Market Share by Application (2017-2022)

2.5.3 Global Levonorgestrel API Sale Price by Application (2017-2022)

3 Global Levonorgestrel API by Company

3.1 Global Levonorgestrel API Breakdown Data by Company

3.1.1 Global Levonorgestrel API Annual Sales by Company (2020-2022)

3.1.2 Global Levonorgestrel API Sales Market Share by Company (2020-2022)

3.2 Global Levonorgestrel API Annual Revenue by Company (2020-2022)

3.2.1 Global Levonorgestrel API Revenue by Company (2020-2022)

3.2.2 Global Levonorgestrel API Revenue Market Share by Company (2020-2022)

3.3 Global Levonorgestrel API Sale Price by Company

3.4 Key Manufacturers Levonorgestrel API Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Levonorgestrel API Product Location Distribution

3.4.2 Players Levonorgestrel API Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Levonorgestrel API by Geographic Region

4.1 World Historic Levonorgestrel API Market Size by Geographic Region (2017-2022)

4.1.1 Global Levonorgestrel API Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Levonorgestrel API Annual Revenue by Geographic Region

4.2 World Historic Levonorgestrel API Market Size by Country/Region (2017-2022)

4.2.1 Global Levonorgestrel API Annual Sales by Country/Region (2017-2022)

4.2.2 Global Levonorgestrel API Annual Revenue by Country/Region

4.3 Americas Levonorgestrel API Sales Growth

4.4 APAC Levonorgestrel API Sales Growth

4.5 Europe Levonorgestrel API Sales Growth

4.6 Middle East & Africa Levonorgestrel API Sales Growth

5 Americas

5.1 Americas Levonorgestrel API Sales by Country

5.1.1 Americas Levonorgestrel API Sales by Country (2017-2022)

5.1.2 Americas Levonorgestrel API Revenue by Country (2017-2022)

5.2 Americas Levonorgestrel API Sales by Type

5.3 Americas Levonorgestrel API Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Levonorgestrel API Sales by Region

6.1.1 APAC Levonorgestrel API Sales by Region (2017-2022)

6.1.2 APAC Levonorgestrel API Revenue by Region (2017-2022)

6.2 APAC Levonorgestrel API Sales by Type

6.3 APAC Levonorgestrel API Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Levonorgestrel API by Country

7.1.1 Europe Levonorgestrel API Sales by Country (2017-2022)

7.1.2 Europe Levonorgestrel API Revenue by Country (2017-2022)

7.2 Europe Levonorgestrel API Sales by Type

7.3 Europe Levonorgestrel API Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Levonorgestrel API by Country

8.1.1 Middle East & Africa Levonorgestrel API Sales by Country (2017-2022)

8.1.2 Middle East & Africa Levonorgestrel API Revenue by Country (2017-2022)

8.2 Middle East & Africa Levonorgestrel API Sales by Type

8.3 Middle East & Africa Levonorgestrel API Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Levonorgestrel API

10.3 Manufacturing Process Analysis of Levonorgestrel API

10.4 Industry Chain Structure of Levonorgestrel API

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Levonorgestrel API Distributors

11.3 Levonorgestrel API Customer

12 World Forecast Review for Levonorgestrel API by Geographic Region

12.1 Global Levonorgestrel API Market Size Forecast by Region

12.1.1 Global Levonorgestrel API Forecast by Region (2023-2028)

12.1.2 Global Levonorgestrel API Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Levonorgestrel API Forecast by Type

12.7 Global Levonorgestrel API Forecast by Application

13 Key Players Analysis

13.1 ScinoPharm

13.1.1 ScinoPharm Company Information

13.1.2 ScinoPharm Levonorgestrel API Product Offered

13.1.3 ScinoPharm Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 ScinoPharm Main Business Overview

13.1.5 ScinoPharm Latest Developments

13.2 Altaris (3M Drug Delivery Systems)

13.2.1 Altaris (3M Drug Delivery Systems) Company Information

13.2.2 Altaris (3M Drug Delivery Systems) Levonorgestrel API Product Offered

13.2.3 Altaris (3M Drug Delivery Systems) Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Altaris (3M Drug Delivery Systems) Main Business Overview

13.2.5 Altaris (3M Drug Delivery Systems) Latest Developments

13.3 Bayer

13.3.1 Bayer Company Information

13.3.2 Bayer Levonorgestrel API Product Offered

13.3.3 Bayer Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Bayer Main Business Overview

13.3.5 Bayer Latest Developments

13.4 Cipla

13.4.1 Cipla Company Information

13.4.2 Cipla Levonorgestrel API Product Offered

13.4.3 Cipla Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Cipla Main Business Overview

13.4.5 Cipla Latest Developments

13.5 Formos

13.5.1 Formos Company Information

13.5.2 Formos Levonorgestrel API Product Offered

13.5.3 Formos Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Formos Main Business Overview

13.5.5 Formos Latest Developments

13.6 FORTEQ NIDAU AG

13.6.1 FORTEQ NIDAU AG Company Information

13.6.2 FORTEQ NIDAU AG Levonorgestrel API Product Offered

13.6.3 FORTEQ NIDAU AG Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 FORTEQ NIDAU AG Main Business Overview

13.6.5 FORTEQ NIDAU AG Latest Developments

13.7 Gedeon Richter

13.7.1 Gedeon Richter Company Information

13.7.2 Gedeon Richter Levonorgestrel API Product Offered

13.7.3 Gedeon Richter Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Gedeon Richter Main Business Overview

13.7.5 Gedeon Richter Latest Developments

13.8 Hangzhou Longshine Bio-Tec

13.8.1 Hangzhou Longshine Bio-Tec Company Information

13.8.2 Hangzhou Longshine Bio-Tec Levonorgestrel API Product Offered

13.8.3 Hangzhou Longshine Bio-Tec Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Hangzhou Longshine Bio-Tec Main Business Overview

13.8.5 Hangzhou Longshine Bio-Tec Latest Developments

13.9 Hubei Gedian Humanwell Pharmaceutical

13.9.1 Hubei Gedian Humanwell Pharmaceutical Company Information

13.9.2 Hubei Gedian Humanwell Pharmaceutical Levonorgestrel API Product Offered

13.9.3 Hubei Gedian Humanwell Pharmaceutical Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Hubei Gedian Humanwell Pharmaceutical Main Business Overview

13.9.5 Hubei Gedian Humanwell Pharmaceutical Latest Developments

13.10 Indo Phyto Chemicals

13.10.1 Indo Phyto Chemicals Company Information

13.10.2 Indo Phyto Chemicals Levonorgestrel API Product Offered

13.10.3 Indo Phyto Chemicals Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Indo Phyto Chemicals Main Business Overview

13.10.5 Indo Phyto Chemicals Latest Developments

13.11 Industriale Chimica

13.11.1 Industriale Chimica Company Information

13.11.2 Industriale Chimica Levonorgestrel API Product Offered

13.11.3 Industriale Chimica Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Industriale Chimica Main Business Overview

13.11.5 Industriale Chimica Latest Developments

13.12 Jenapharm

13.12.1 Jenapharm Company Information

13.12.2 Jenapharm Levonorgestrel API Product Offered

13.12.3 Jenapharm Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Jenapharm Main Business Overview

13.12.5 Jenapharm Latest Developments

13.13 Lupin

13.13.1 Lupin Company Information

13.13.2 Lupin Levonorgestrel API Product Offered

13.13.3 Lupin Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Lupin Main Business Overview

13.13.5 Lupin Latest Developments

13.14 Naari

13.14.1 Naari Company Information

13.14.2 Naari Levonorgestrel API Product Offered

13.14.3 Naari Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Naari Main Business Overview

13.14.5 Naari Latest Developments

13.15 Qinhuangdao Zizhu Pharmaceutical

13.15.1 Qinhuangdao Zizhu Pharmaceutical Company Information

13.15.2 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Product Offered

13.15.3 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Qinhuangdao Zizhu Pharmaceutical Main Business Overview

13.15.5 Qinhuangdao Zizhu Pharmaceutical Latest Developments

13.16 Sterling Chemical Malta Ltd

13.16.1 Sterling Chemical Malta Ltd Company Information

13.16.2 Sterling Chemical Malta Ltd Levonorgestrel API Product Offered

13.16.3 Sterling Chemical Malta Ltd Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Sterling Chemical Malta Ltd Main Business Overview

13.16.5 Sterling Chemical Malta Ltd Latest Developments

13.17 Symbiotec Pharmalab

13.17.1 Symbiotec Pharmalab Company Information

13.17.2 Symbiotec Pharmalab Levonorgestrel API Product Offered

13.17.3 Symbiotec Pharmalab Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Symbiotec Pharmalab Main Business Overview

13.17.5 Symbiotec Pharmalab Latest Developments

13.18 Yangzhou Pharmaceutical

13.18.1 Yangzhou Pharmaceutical Company Information

13.18.2 Yangzhou Pharmaceutical Levonorgestrel API Product Offered

13.18.3 Yangzhou Pharmaceutical Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Yangzhou Pharmaceutical Main Business Overview

13.18.5 Yangzhou Pharmaceutical Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Levonorgestrel API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Levonorgestrel API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Short-Acting Contraceptive API

Table 4. Major Players of Long-Acting Contraceptive API

Table 5. Global Levonorgestrel API Sales by Type (2017-2022) & (KG)

Table 6. Global Levonorgestrel API Sales Market Share by Type (2017-2022)

Table 7. Global Levonorgestrel API Revenue by Type (2017-2022) & ($ million)

Table 8. Global Levonorgestrel API Revenue Market Share by Type (2017-2022)

Table 9. Global Levonorgestrel API Sale Price by Type (2017-2022) & (US$/G)

Table 10. Global Levonorgestrel API Sales by Application (2017-2022) & (KG)

Table 11. Global Levonorgestrel API Sales Market Share by Application (2017-2022)

Table 12. Global Levonorgestrel API Revenue by Application (2017-2022)

Table 13. Global Levonorgestrel API Revenue Market Share by Application (2017-2022)

Table 14. Global Levonorgestrel API Sale Price by Application (2017-2022) & (US$/G)

Table 15. Global Levonorgestrel API Sales by Company (2020-2022) & (KG)

Table 16. Global Levonorgestrel API Sales Market Share by Company (2020-2022)

Table 17. Global Levonorgestrel API Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Levonorgestrel API Revenue Market Share by Company (2020-2022)

Table 19. Global Levonorgestrel API Sale Price by Company (2020-2022) & (US$/G)

Table 20. Key Manufacturers Levonorgestrel API Producing Area Distribution and Sales Area

Table 21. Players Levonorgestrel API Products Offered

Table 22. Levonorgestrel API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Levonorgestrel API Sales by Geographic Region (2017-2022) & (KG)

Table 26. Global Levonorgestrel API Sales Market Share Geographic Region (2017-2022)

Table 27. Global Levonorgestrel API Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Levonorgestrel API Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Levonorgestrel API Sales by Country/Region (2017-2022) & (KG)

Table 30. Global Levonorgestrel API Sales Market Share by Country/Region (2017-2022)

Table 31. Global Levonorgestrel API Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Levonorgestrel API Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Levonorgestrel API Sales by Country (2017-2022) & (KG)

Table 34. Americas Levonorgestrel API Sales Market Share by Country (2017-2022)

Table 35. Americas Levonorgestrel API Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Levonorgestrel API Revenue Market Share by Country (2017-2022)

Table 37. Americas Levonorgestrel API Sales by Type (2017-2022) & (KG)

Table 38. Americas Levonorgestrel API Sales Market Share by Type (2017-2022)

Table 39. Americas Levonorgestrel API Sales by Application (2017-2022) & (KG)

Table 40. Americas Levonorgestrel API Sales Market Share by Application (2017-2022)

Table 41. APAC Levonorgestrel API Sales by Region (2017-2022) & (KG)

Table 42. APAC Levonorgestrel API Sales Market Share by Region (2017-2022)

Table 43. APAC Levonorgestrel API Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Levonorgestrel API Revenue Market Share by Region (2017-2022)

Table 45. APAC Levonorgestrel API Sales by Type (2017-2022) & (KG)

Table 46. APAC Levonorgestrel API Sales Market Share by Type (2017-2022)

Table 47. APAC Levonorgestrel API Sales by Application (2017-2022) & (KG)

Table 48. APAC Levonorgestrel API Sales Market Share by Application (2017-2022)

Table 49. Europe Levonorgestrel API Sales by Country (2017-2022) & (KG)

Table 50. Europe Levonorgestrel API Sales Market Share by Country (2017-2022)

Table 51. Europe Levonorgestrel API Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Levonorgestrel API Revenue Market Share by Country (2017-2022)

Table 53. Europe Levonorgestrel API Sales by Type (2017-2022) & (KG)

Table 54. Europe Levonorgestrel API Sales Market Share by Type (2017-2022)

Table 55. Europe Levonorgestrel API Sales by Application (2017-2022) & (KG)

Table 56. Europe Levonorgestrel API Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Levonorgestrel API Sales by Country (2017-2022) & (KG)

Table 58. Middle East & Africa Levonorgestrel API Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Levonorgestrel API Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Levonorgestrel API Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Levonorgestrel API Sales by Type (2017-2022) & (KG)

Table 62. Middle East & Africa Levonorgestrel API Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Levonorgestrel API Sales by Application (2017-2022) & (KG)

Table 64. Middle East & Africa Levonorgestrel API Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Levonorgestrel API

Table 66. Key Market Challenges & Risks of Levonorgestrel API

Table 67. Key Industry Trends of Levonorgestrel API

Table 68. Levonorgestrel API Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Levonorgestrel API Distributors List

Table 71. Levonorgestrel API Customer List

Table 72. Global Levonorgestrel API Sales Forecast by Region (2023-2028) & (KG)

Table 73. Global Levonorgestrel API Sales Market Forecast by Region

Table 74. Global Levonorgestrel API Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Levonorgestrel API Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Levonorgestrel API Sales Forecast by Country (2023-2028) & (KG)

Table 77. Americas Levonorgestrel API Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Levonorgestrel API Sales Forecast by Region (2023-2028) & (KG)

Table 79. APAC Levonorgestrel API Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Levonorgestrel API Sales Forecast by Country (2023-2028) & (KG)

Table 81. Europe Levonorgestrel API Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Levonorgestrel API Sales Forecast by Country (2023-2028) & (KG)

Table 83. Middle East & Africa Levonorgestrel API Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Levonorgestrel API Sales Forecast by Type (2023-2028) & (KG)

Table 85. Global Levonorgestrel API Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Levonorgestrel API Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Levonorgestrel API Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Levonorgestrel API Sales Forecast by Application (2023-2028) & (KG)

Table 89. Global Levonorgestrel API Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Levonorgestrel API Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Levonorgestrel API Revenue Market Share Forecast by Application (2023-2028)

Table 92. ScinoPharm Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors

Table 93. ScinoPharm Levonorgestrel API Product Offered

Table 94. ScinoPharm Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 95. ScinoPharm Main Business

Table 96. ScinoPharm Latest Developments

Table 97. Altaris (3M Drug Delivery Systems) Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors

Table 98. Altaris (3M Drug Delivery Systems) Levonorgestrel API Product Offered

Table 99. Altaris (3M Drug Delivery Systems) Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 100. Altaris (3M Drug Delivery Systems) Main Business

Table 101. Altaris (3M Drug Delivery Systems) Latest Developments

Table 102. Bayer Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors

Table 103. Bayer Levonorgestrel API Product Offered

Table 104. Bayer Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 105. Bayer Main Business

Table 106. Bayer Latest Developments

Table 107. Cipla Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors

Table 108. Cipla Levonorgestrel API Product Offered

Table 109. Cipla Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 110. Cipla Main Business

Table 111. Cipla Latest Developments

Table 112. Formos Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors

Table 113. Formos Levonorgestrel API Product Offered

Table 114. Formos Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 115. Formos Main Business

Table 116. Formos Latest Developments

Table 117. FORTEQ NIDAU AG Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors

Table 118. FORTEQ NIDAU AG Levonorgestrel API Product Offered

Table 119. FORTEQ NIDAU AG Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 120. FORTEQ NIDAU AG Main Business

Table 121. FORTEQ NIDAU AG Latest Developments

Table 122. Gedeon Richter Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors

Table 123. Gedeon Richter Levonorgestrel API Product Offered

Table 124. Gedeon Richter Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 125. Gedeon Richter Main Business

Table 126. Gedeon Richter Latest Developments

Table 127. Hangzhou Longshine Bio-Tec Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors

Table 128. Hangzhou Longshine Bio-Tec Levonorgestrel API Product Offered

Table 129. Hangzhou Longshine Bio-Tec Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 130. Hangzhou Longshine Bio-Tec Main Business

Table 131. Hangzhou Longshine Bio-Tec Latest Developments

Table 132. Hubei Gedian Humanwell Pharmaceutical Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors

Table 133. Hubei Gedian Humanwell Pharmaceutical Levonorgestrel API Product Offered

Table 134. Hubei Gedian Humanwell Pharmaceutical Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 135. Hubei Gedian Humanwell Pharmaceutical Main Business

Table 136. Hubei Gedian Humanwell Pharmaceutical Latest Developments

Table 137. Indo Phyto Chemicals Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors

Table 138. Indo Phyto Chemicals Levonorgestrel API Product Offered

Table 139. Indo Phyto Chemicals Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 140. Indo Phyto Chemicals Main Business

Table 141. Indo Phyto Chemicals Latest Developments

Table 142. Industriale Chimica Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors

Table 143. Industriale Chimica Levonorgestrel API Product Offered

Table 144. Industriale Chimica Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 145. Industriale Chimica Main Business

Table 146. Industriale Chimica Latest Developments

Table 147. Jenapharm Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors

Table 148. Jenapharm Levonorgestrel API Product Offered

Table 149. Jenapharm Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 150. Jenapharm Main Business

Table 151. Jenapharm Latest Developments

Table 152. Lupin Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors

Table 153. Lupin Levonorgestrel API Product Offered

Table 154. Lupin Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 155. Lupin Main Business

Table 156. Lupin Latest Developments

Table 157. Naari Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors

Table 158. Naari Levonorgestrel API Product Offered

Table 159. Naari Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 160. Naari Main Business

Table 161. Naari Latest Developments

Table 162. Qinhuangdao Zizhu Pharmaceutical Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors

Table 163. Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Product Offered

Table 164. Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 165. Qinhuangdao Zizhu Pharmaceutical Main Business

Table 166. Qinhuangdao Zizhu Pharmaceutical Latest Developments

Table 167. Sterling Chemical Malta Ltd Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors

Table 168. Sterling Chemical Malta Ltd Levonorgestrel API Product Offered

Table 169. Sterling Chemical Malta Ltd Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 170. Sterling Chemical Malta Ltd Main Business

Table 171. Sterling Chemical Malta Ltd Latest Developments

Table 172. Symbiotec Pharmalab Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors

Table 173. Symbiotec Pharmalab Levonorgestrel API Product Offered

Table 174. Symbiotec Pharmalab Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 175. Symbiotec Pharmalab Main Business

Table 176. Symbiotec Pharmalab Latest Developments

Table 177. Yangzhou Pharmaceutical Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors

Table 178. Yangzhou Pharmaceutical Levonorgestrel API Product Offered

Table 179. Yangzhou Pharmaceutical Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 180. Yangzhou Pharmaceutical Main Business

Table 181. Yangzhou Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Levonorgestrel API

Figure 2. Levonorgestrel API Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Levonorgestrel API Sales Growth Rate 2017-2028 (KG)

Figure 7. Global Levonorgestrel API Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Levonorgestrel API Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Short-Acting Contraceptive API

Figure 10. Product Picture of Long-Acting Contraceptive API

Figure 11. Global Levonorgestrel API Sales Market Share by Type in 2021

Figure 12. Global Levonorgestrel API Revenue Market Share by Type (2017-2022)

Figure 13. Levonorgestrel API Consumed in Table

Figure 14. Global Levonorgestrel API Market: Table (2017-2022) & (KG)

Figure 15. Levonorgestrel API Consumed in Mixture Products

Figure 16. Global Levonorgestrel API Market: Mixture Products (2017-2022) & (KG)

Figure 17. Levonorgestrel API Consumed in Other

Figure 18. Global Levonorgestrel API Market: Other (2017-2022) & (KG)

Figure 19. Global Levonorgestrel API Sales Market Share by Application (2017-2022)

Figure 20. Global Levonorgestrel API Revenue Market Share by Application in 2021

Figure 21. Levonorgestrel API Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Levonorgestrel API Revenue Market Share by Company in 2021

Figure 23. Global Levonorgestrel API Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Levonorgestrel API Revenue Market Share by Geographic Region in 2021

Figure 25. Global Levonorgestrel API Sales Market Share by Region (2017-2022)

Figure 26. Global Levonorgestrel API Revenue Market Share by Country/Region in 2021

Figure 27. Americas Levonorgestrel API Sales 2017-2022 (KG)

Figure 28. Americas Levonorgestrel API Revenue 2017-2022 ($ Millions)

Figure 29. APAC Levonorgestrel API Sales 2017-2022 (KG)

Figure 30. APAC Levonorgestrel API Revenue 2017-2022 ($ Millions)

Figure 31. Europe Levonorgestrel API Sales 2017-2022 (KG)

Figure 32. Europe Levonorgestrel API Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Levonorgestrel API Sales 2017-2022 (KG)

Figure 34. Middle East & Africa Levonorgestrel API Revenue 2017-2022 ($ Millions)

Figure 35. Americas Levonorgestrel API Sales Market Share by Country in 2021

Figure 36. Americas Levonorgestrel API Revenue Market Share by Country in 2021

Figure 37. United States Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Levonorgestrel API Sales Market Share by Region in 2021

Figure 42. APAC Levonorgestrel API Revenue Market Share by Regions in 2021

Figure 43. China Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Levonorgestrel API Sales Market Share by Country in 2021

Figure 50. Europe Levonorgestrel API Revenue Market Share by Country in 2021

Figure 51. Germany Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Levonorgestrel API Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Levonorgestrel API Revenue Market Share by Country in 2021

Figure 58. Egypt Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Levonorgestrel API in 2021

Figure 64. Manufacturing Process Analysis of Levonorgestrel API

Figure 65. Industry Chain Structure of Levonorgestrel API

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390